Estrella Immunopharma, Inc. (ESLA) stock
ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33+0.00 (+0.39%)
Close on Nov 18, 2026Market cap $14.48MP/E –Yield –
Estrella Immunopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Estrella Immunopharma's price to book ratio was 6.1× on Jul 31, 2026, against 7.2× a year earlier. Over the last 3 years it ranged from 3.9× to 20.7×, with a median of 8.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 6.1× | −7.2 |
| 2025 | Dec 31, 2025 | 13.4× | +3.1 |
| 2024 | Dec 31, 2024 | 10.3× | +6.4 |
| 2023 | Dec 29, 2023 | 3.9× | – |
See a number that looks wrong?